In the last trading session, 3.95 million ProKidney Corp (NASDAQ:PROK) shares changed hands as the company’s beta touched 1.61. With the company’s per share price
In last trading session, ProKidney Corp (NASDAQ:PROK) saw 7.4 million shares changing hands with its beta currently measuring 1.41. Company’s recent per share price level
ProKidney Corp (NASDAQ:PROK) has a beta value of 1.61 and has seen 17.53 million shares traded in the last trading session. The company, currently valued
During the last session, ProKidney Corp (NASDAQ:PROK)’s traded shares were 209.37 million, with the beta value of the company hitting 1.11. At the end of
In the last trading session, 1.54 million shares of the ProKidney Corp (NASDAQ:PROK) were traded, and its beta was 1.37. Most recently the company’s share
In the last trading session, 12.35 million ProKidney Corp (NASDAQ:PROK) shares changed hands as the company’s beta touched 1.45. With the company’s per share price
In last trading session, ProKidney Corp (NASDAQ:PROK) saw 3.07 million shares changing hands with its beta currently measuring 1.43. Company’s recent per share price level
ProKidney Corp (NASDAQ:PROK) has a beta value of -93.35% and has seen 818.02 shares traded in the last trading session. The company, currently valued at
In the last trading session, 1.16 million shares of the ProKidney Corp (NASDAQ:PROK) were traded, and its beta was 1.50. Most recently the company’s share
In last trading session, ProKidney Corp (NASDAQ:PROK) saw 0.57 million shares changing hands with its beta currently measuring 1.11. Company’s recent per share price level
Marketing Sentinel delivers exclusive content, news, articles, and comprehensive coverage of events in the USA and worldwide with a commitment to reliability, objectivity, and timeliness.
© 2024, Powered by Smart TechOne